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Available online 30 April 2016Taste signals and nutrient stimuli sensed by the gastrointestinal tract are transmitted to the brain to regulate feeding
behavior and energy homeostasis. This system is referred to as the gut-brain axis. Here we show that both brush
cells and type II taste cells are eliminated in the gastrointestinal tract of transcription factor Skn-1 knockout (KO)
mice. Despite unaltered food intake, Skn-1 KO mice have reduced body weight with lower body fat due to increased
energy expenditure. In this model, 24-h urinary excretion of catecholamines was signiﬁcantly elevated, accompanied
by increased fatty acidβ-oxidation and fuel dissipation in skeletalmuscle and impaired insulin secretion driven by glu-
cose. These results suggest the existence of brain-mediated energy homeostatic pathways originating from brush cells
and type II taste cells in the gastrointestinal tract and ending in peripheral tissues, including the adrenal glands. The dis-
covery of food-derived factors that regulate these cells may open new avenues the treatment of obesity and diabetes.
Research Context: Taste signals and nutrient stimuli sensed by the gastrointestinal tract are transmitted to the brain to
regulate feeding behavior and energy homeostasis along the gut-brain axis. We propose the concept that taste-receiv-
ing cells in the oral cavity and/or food-borne chemicals-receiving brush cells in the gut are involved in regulation of the
bodyweight and adiposity via the brain. The discovery of food-derived factors that regulate these cells may open new
avenues for the treatment of obesity and diabetes.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Taste signals and nutrient stimuli sensed by the gastrointestinal (GI)
tract are transmitted to the central nervous system, including the nucle-
us of the solitary tract and hypothalamus, via afferent neurons and hu-
moral mediators, thereby controlling feeding behavior and energy
homeostasis. This system is referred to as the gut-brain axis
(Cummings and Overduin, 2007; Furness, 2012). This information is
subsequently conveyed from the brain to peripheral tissues via efferent
sympathetic and parasympathetic nerves including preganglionic sym-
pathetic splanchnic input to the adrenal glands. For example, gut
incretins such as glucose-dependent insulinotropic peptide (GIP) and
glucagon-like peptide-1 (GLP-1), which are released from the intestinal
enteroendocrine cells in response to nutrient ingestion, potentiate glu-
cose-stimulated insulin secretion (GSIS) from pancreatic β-cells (Wu
et al., 2015). GLP-1 also activates the GLP-1 receptors expressed on
vagal afferent nerve terminals in the portal vein and in the brain acrossthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Katsurada et al., 2014; Kinzig et al., 2002; Vahl et al., 2007). Gavage of
agonists for bitter taste receptor increases food intake via the secretion
of ghrelin, a hormone that potentiates hunger sensation (Janssen et al.,
2011).
The Skn-1 (also known as Pou2f3) gene, which encodes the POU
homeodomain transcription factor, was originally identiﬁed as a regula-
tor of the differentiation of epidermal keratinocytes (Andersen et al.,
1993, 1997). We previously reported that Skn-1a is expressed in
sweet, umami (savory), and bitter-sensing taste cells, which are re-
ferred to as type II taste cells (Matsumoto et al., 2011). Type II taste
cells are completely eliminated in Skn-1 knockout (KO) mice, resulting
in loss of electrophysiological and behavioral responses to sweet,
umami, and bitter tastes. Thus, Skn-1a is critical for generating type II
taste cells. Skn-1a is also required for the generation of Trpm5-express-
ing solitary chemosensory cells (SCCs) in the nasal respiratory epitheli-
um and microvillous cells in the main olfactory epithelium (Ohmoto et
al., 2013; Yamaguchi et al., 2014). Skn-1a is expressed in several tissues
including the stomach, but not in the brain (Yukawa et al., 1993).
There are four major cell types in the small intestine: enterocytes
and Goblet, Paneth, and enteroendocrine cells (van der Flier and
Clevers, 2009). In addition to these cell types, brush cells (also referred
to as tuft cells or caveolated cells) constitute a minor fraction (0.4%) of
the adult mouse intestinal epithelium (Gerbe et al., 2012). Brush cells
are supposed to be chemosensory cells (Young, 2011) and express tran-
sient receptor potential melastatin 5 (Trpm5), Doublecortin-like kinase
1 (Dclk1), and choline acetyltransferase (Bezencon et al., 2008; Gerbe
et al., 2009, 2011; Saqui-Salces et al., 2011; Schütz et al., 2015). The
mechanisms of differentiation and the function of brush cells remain
elusive.
In the present study, we found that Skn-1a regulates differentiation
of Trpm5-expressing brush cells in the GI tract. Skn-1 KOmice exhibited
reduced body weight with lower body fat than wild-type (WT) litter-
mates. Despite unaltered food intake, Skn-1 KO mice exhibited in-
creased energy expenditure, caused by augmented catecholamine
secretion. Our work raises the concept that taste cells receiving sweet,
bitter, and umami tastes as well as brush cells receiving food-borne
chemicals are involved in regulating body weight and body fat. Collec-
tively, the present study provides new insights into the regulation of en-
ergy homeostasis originating from brush cells and taste cells in the GI
tract and signaling to peripheral tissues including the adrenal glands,
via the brain.
2. Material and Methods
2.1. Experimental Animals
All animal experiments were approved by the Animal Care and Use
Committee at The University of Tokyo. Skn-1/Pou2f3-deﬁcient mice
with a mixed 129 × C57BL/6J backgroundwere generated as previously
described (Matsumoto et al., 2011) and then backcrossed to C57BL/6J
for N10 generations. Male Skn-1 KOmice and their WT littermates gen-
erated by crossing the heterozygous mice were used in the present
study. Mice were fed a normal chow diet (Lab MR Breeder, Nosan Co.,
Yokohama, Japan) after weaning or High-Fat Diet 32 (CREA Japan Inc.,
Tokyo, Japan) from 4weeks of age for N12weeks to induce dietary obe-
sity. Mice were maintained in a room with a constant temperature of
22± 1 °C under a 12-h light-dark cycle (lights on at 8 a.m.). Tissue sam-
ples were collected from 12- to 16-week-old mice that were fasted for
18 h.
2.2. X-ray Computed Tomography (CT) Scan Analysis
Mice older than 16 weeks were anesthetized using an isoﬂurane
nebulizer (Muromachi Kikai Co. Ltd., Tokyo, Japan); a Latheta LCT-200CT instrument (Aloka-Hitachi LCT-200, Tokyo, Japan) was then used to
scan abdominal fat and muscle mass and extract thighbone density.
2.3. Blood Chemical Parameters
Bloodwas collected from approximately 20-week-oldmice by cardi-
ac puncture at 10 a.m. under ad libitum feeding condition and after 18-h
fasting. Serum chemical parameters and hormones (PTH, T3, and T4)
were analyzed by Nagahama Life Science Laboratory (Shiga, Japan).
Plasma insulin and leptin weremeasured using the Luminex 200™ Sys-
tem (Luminex, Austin, TX, USA) by GeneticLab Co., Ltd. (Sapporo,
Japan). Plasma adiponectin and FGF21 were measured using mouse
adiponectin ELISA (BioVender, Brno, Czech Republic) and mouse and
rat FGF-21 ELISA (BioVender), respectively.
2.4. Indirect Calorimetry
Indirect calorimetry was performed on 20- to 28-week-old mice
using an indirect calorimeter (ARCO-2000, Arco Systems Inc., Chiba,
Japan) and spontaneousmotor activity wasmeasured using a pyroelec-
tric infrared ray sensor (NS-AS01, Neuroscience Inc., Tokyo, Japan) for
3–4 days after 2 days of habituation essentially as described by Tschop
et al. (2011) or with an indirect calorimeter (MK-5000RQ, Muromachi
Kikai Co. Ltd.) as previously described (Watanabe et al., 2014). The re-
spiratory exchange ratio (RER) was calculated as the molar ratio of
VCO2/VO2. Energy expenditure (kcal per hour) was calculated as heat
(kcal/h) = (3.815 + 1.232 × RER) × VO2.
2.5. Mitochondrial DNA Copy Number
To measure the mitochondrial DNA copy number, the ratio of mito-
chondrial DNA to genomic DNA was calculated by a previously de-
scribed method (Watanabe et al., 2014). In brief, total DNA was
extracted from the gastrocnemius of 14- to 19-week-old mice that
were fasted for 16 h using a QIAamp DNA mini kit (QIAGEN Ltd.,
Tokyo, Japan) and used for qPCR (Applied Biosystems Japan Ltd.,
Tokyo, Japan). We used the TaqMan Gene Expression Assay (Applied
Biosystems Foster City, USA; ACTB, Mm00607939_s1; CYTB,
Mm044225274). The PCR cycling conditions were 50 °C for 2 min, 95 °
C for 10min, and 40 cycles of 95 °C for 15 s and 60 °C for 1 min. Themi-
tochondrial DNA copy number is presented relative to nuclear DNA fol-
lowing ampliﬁcation of the mitochondrial gene region (cytochrome b
vs. the nuclear endogenous control region, β-actin).
2.6. DNA Microarray
DNAmicroarray analysis using total RNA extracted from the gastroc-
nemius of 12- to 16-week-old mice that were fasted for 18 h was per-
formed as previously described (Nakai et al., 2008) with minor
modiﬁcations. In brief, Total RNA samples (100 ng each) were prepared
and processed for microarray analysis using a 3′ IVT Express kit and
GeneChip® Mouse Genome 430 2.0 Array (Affymetrix, Santa Clara, CA,
USA) according to the manufacturer's standard protocols. The raw mi-
croarray data (CEL ﬁles) were quantiﬁed by the Factor Analysis for Ro-
bust Microarray Summarization (FARMS) (Hochreiter et al., 2006)
using the statistical language R (Team and Computing, 2005) and
Bioconductor (Gentleman et al., 2004). To identify differentially
expressed genes, the rank products (RP) method (Breitling et al.,
2004) was applied to the FARMS-quantiﬁed data. All microarray data
are MIAME compliant and have been deposited in a MIAME-compliant
database, the National Center for Biotechnology Information (NCBI)
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/, GEO Se-
ries accession number GSE76936), as described in more detail on the
MGED Society web site (http://www.mged.org/Workgroups/MIAME/
miame.html).
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Fecal lipidswere extracted from dried feces of 15-week-oldmice fed
a HFD according to the Folch method (Folch et al., 1957), and the TG
concentration was measured using the Wako triglyceride E-Test
(Wako Pure Chemical Industries, Ltd., Osaka, Japan). The total energy
content of feces collected for 8 weeks was measured by bomb
calorimetry.
2.8. Measurement of Urine Catecholamines
Twenty-four-hour urine (for catecholamine measurements) was
collected into collection vials from11- to 12-week-oldmice individually
housed in metabolic cages. To avoid spontaneous oxidation ofFig. 1. Brush cells are eliminated in the GI tract of Skn-1 KO mice. (a) Tissue distribution of Skn
papillae, stomach, duodenum, jejunum, and ileum but absent or only faintly expressed in all
muscle, white adipose tissue (WAT), and brown adipose tissue (BAT). (b) Immunostaining
(upper panel) and in a subset of cells in the small intestine (lower panel). Inset in the upper
dashed box. (c) In situ hybridization revealed that Trpm5mRNA was expressed in the jejunum
revealed Dclk1 signals in WT mice (upper panel) but not Skn-1 KO mice (lower panel). The
Trpm5-positive cells were also positive for Skn-1a. The arrows indicate cells expressing Trpm5catecholamine, 60 μL of hydrochloric acid (6 mol/L) was added to the
collection vials (Moreira-Rodrigues et al., 2012). The collected urine
was puriﬁed using MonoSpin PBA (GL Sciences, Tokyo, Japan) and
urine catecholamines were measured by HPLC as previously described
(Tsunoda et al., 2011). In brief, Chromatography was performed using
an Inertsil ODS-4 column (5 μm, 250 × 20 mm i.d., GL Science) with ac-
etate-citrate buffer at a ﬂow rate of 0.5mL/min and detected by electro-
chemical detection. The concentration of urine creatininewasmeasured
using a LabAssay™ Creatinine kit (Wako Pure Chemical Industries, Ltd.).
2.9. qRT-PCR in Adrenal Glands
Total RNAwas extracted fromadrenal glands usingRNeasymini-col-
umns (Qiagen, Venlo, Netherlands), followed by genomic DNA-1a. RT-PCR analysis revealed that Skn-1awas abundantly expressed in the circumvallate
other tissues examined, including the pancreas, islets of Langerhans, brain, liver, skeletal
revealed strong Skn-1a signals in the corpus beneath the limiting ridge in the stomach
right corner of each panel shows higher magniﬁcation image of the area enclosed by the
of WT mice (upper panel) but not in Skn-1 KO mice (lower panel). (d) Immunostaining
arrowheads indicate signals. (e) Double immunostaining demonstrated that nearly all
and Skn-1a. Scale bars: 100 μm and 25 μm (inset). See also Fig. S1.
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erated by reverse transcription from total RNA (Superscript III Reverse
Transcription Kit; Life Technologies, Gaithersburg, MD). Levels of
mRNA transcripts were determined by qPCR (ABI Prism 7000 Se-
quence Detection System, Applied Biosystems, Foster City, CA).
cDNA levels were normalized against β-actin. PCR ampliﬁcation
was performed using TaqMan technology (TaqMan Gene ExpressionFig. 2.Metabolic phenotypes of Skn-1 KOmice fed a normal chow diet. (a) Changes in bodywei
lower bodyweight than theirWT littermates for 13weeks after weaning (n N 75). Also see Fig. S
there was no signiﬁcant difference inmuscle mass percentage between the two genotypes (n=
theirWT littermates under ad libitum feeding (n=18–28) (c) and 18-h fasting conditions (n=
8). (f) Skn-1 KOmice exhibited increased energy expenditure compared with theirWT litterma
muscle was signiﬁcantly higher in Skn-1 KO mice than in their WT littermates. The data are prAssays, Applied Biosystems). The TaqMan probe IDs were as
follows: tyrosine hydroxylase (Th; Mm00447557_m1), dopa
decarboxylase (Ddc; Mm00516688_m1), dopamine β-hydroxylase
(Dbh; Mm00460472_m1), phenylethanolamine N-methyltransfer-
ase (Pnmt; Mm00476993_m1), and β-actin (Mm00607939_s1).
The delta-delta method was used for relative quantiﬁcation (Livak
and Schmittgen, 2001).ght under normal chow diet conditions. When fed a normal chow diet, Skn-1 KOmice had
2A. (b) Skn-1KOmice had a lower body fat percentage than theirWT littermates, whereas
10–19). (c and d) Serum levels of total ketone bodies were higher in Skn-1 KOmice than
13) (d). (e) Skn-1KOandWT littermates had similar food intake at 8weeks of age (n=5–
tes (n= 9). (g) qRT-PCR analysis revealed that themitochondrial DNA content in skeletal
esented as the mean ± SEM; **p b 0.01 and *p b 0.05. See also Fig. S2.
Table 1
Up-regulated genes related to mitochondrial function in skeletal muscle.
Gene symbol Gene name Probe ID
ABCD2 ATP-binding cassette, sub-family D
(ALD), member 2
1419748_at
Ociad2 OCIA domain containing 2 1435917_at
Pptc7 PTC7 protein phosphatase homolog (S.
cerevisiae)
1455958_s_at
4930402E16Rik RIKEN cDNA4930402E16Rik gene 1459869_x_at
8430408G22Rik RIKEN cDNA 8430408G22 gene 1433837_at
Tbc1d15 TBC1 domain family, member 15 1416062_at
Xaf1 XIAP associated factor 1 1443698_at
Col4a3bp Collagen, type IV, alpha 3
(Goodpasture antigen) binding
protein
1420384_at
Dsp Desmoplakin 1435493_at,
1435494_s_at
DlaT Dihydrolipoamide S-acetyltransferase
(E2 component of pyruvate
dehydrogenase complex)
1426264_at,
1426265_x_at
Fdx1 Ferredoxin 1 1449108_at
Gpam Glycerol-3-phosphate acyltransferase,
mitochondrial
1419499_at
Hk2 Hexokinase 2 1422612_at
Coq10b Coenzyme Q10 homolog B (S.
cerevisiae)
1460510_a_at
Immt Inner membrane protein,
mitochondrial
1429533_at
Ide Insulin degrading enzyme 1423121_at,
1435140_at
Krt5 Keratin 5 1424096_at
Kif1b Kinesin family member 1B 1423995_at,
1451642_at,
1451200_at,
1425270_at
Elovl6 ELOVL family member 6, elongation of
long chain fatty acids (yeast)
1417403_at
Csde1 Cold shock domain containing E1, RNA
binding
1423997_at
Prkca Protein kinase C, alpha 1437393_at,
1446598_at,
1450945_at
Ppm1k Protein phosphatase 1K (PP2C domain
containing)
1441988_at
Ppp3ca Protein phosphatase 3, catalytic
subunit, alpha isoform
1426401_at,
1438478_a_at
Reep1 Receptor accessory protein 1 1433509_s_at
ND5 NADH dehydrogenase subunit 5 1426088_at
Opa1 Optic atrophy 1 1434890_at
Slc25a12 Solute carrier family 25
(mitochondrial carrier, Aralar),
member 12
1436440_at
Slc25a25 Solute carrier family 25
(mitochondrial carrier, phosphate
carrier), member 25
1424735_at,
1447856_x_at
Tmtc1 Transmembrane and tetratricopeptide
repeat containing 1
1435261_at
Tap1 Transporter 1, ATP-binding cassette,
sub-family B (MDR/TAP)
1416016_at
Ucp3 Uncoupling protein 3 (mitochondrial,
proton carrier)
1420658_at
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Gavage administration of glucose (3.0 mg/g of bodyweight for mea-
surement of blood glucose, plasma insulin, and plasma total GIP;
5.0 mg/g of body weight for measurement of plasma active GLP-1;
2.0 mg/g of body weight for measurement of blood glucose and plasma
insulin in mice fed a HFD) was performed on 16-week-oldWT and Skn-
1 KO mice at 10 a.m. after 18-h fasting (n = 20–30 animals per group)
using a syringe attached to a feeding needle (KN-349-M1, Natsume
Seisakusho Co. Ltd., Tokyo, Japan) inserted through the mouth into the
stomach. For IPGTT or ITT, mice were fasted for 18 or 4 h, then injected
intraperitoneally with glucose (1.5 mg/g of body weight) or insulin
(0.75 mU/g of body weight), respectively. Tail blood samples were col-
lected from the tail vein before gavage (time 0) and 15, 30, 45, 60, 90,
and 120 min after gavage. For measurement of GIP and GLP-1, tail
blood samples were collected into chilled tubes containing DPP-IV In-
hibitor (Merck Millipore, Billerica, MA) and/or EDTA and aprotinin
(for GLP-1; Wako Pure Chemical Industries, Ltd.) before gavage (time
0) and 15, 30, and 60 min after gavage (for GIP) or 10, 20, and 40 min
after gavage (for GLP-1). Blood glucose, plasma insulin, plasma total
GIP, and plasma active GLP-1 were measured by Glucose Pilot (Iwai
Chemicals Co. Ltd., Tokyo, Japan), Ultra Sensitive Mouse Insulin ELISA
Kit (Morinaga Institute of Biological Science Inc., Kanagawa, Japan),
Rat/Mouse GIP (Total) ELISA Kit (EZRMGIP-55K, Merck Millipore), and
GLP-1 (Active) ELISA Kit (AKMGP-011, Shibayagi Co. Ltd., Gunma,
Japan), respectively.
2.11. RT-PCR
First-strand cDNAs from 11 different tissues except the circumval-
late papillae (Genostaff, Tokyo, Japan)were used for RT-PCR. For the cir-
cumvallate papillae, total RNA was extracted and reverse-transcribed
into cDNAwith an oligo dT primer. Approximately 500 bp of coding re-
gion encompassing multiple exons of Skn-1a was ampliﬁed from each
cDNA for 30 cycles at an annealing temperature of 60 °C. The volume
of PCRproducts for Skn-1a loaded on the agarose gelwas approximately
normalized using the PCR product for GAPDH.
2.12. Islet Isolation and In Vitro Insulin Release From Mouse Islets
Isolated pancreatic islets were prepared by liberase (Roche Diagnos-
tics, Basel, Switzerland) digestion, manually selected, and incubated in
RPMI 1640 tissue culture medium (Life Technologies) supplemented
with 10% (vol/vol) fetal bovine serum at 37 °C overnight. Insulin secre-
tion in vitro was measured in static incubations. Prior to experiments,
islets were pre-incubated for 60min at 37 °C in Krebs-Ringer (KR) buff-
er composed of 119mMNaCl, 4.7mMKCl, 2.5mMCaCl2, 1.2mMMgCl2,
1.2 mM KH2PO4, 25 mM NaHCO3, and 10 mM HEPES (pH 7.4) with 5%
bovine serum albumin. The medium was gassed with 95% O2 and 5%
CO2 to obtain constant pH and oxygenation. The groups of 10 islets
were incubated for 60min at 37 °C in Krebs-Ringer buffer solution con-
taining 2.5 mM glucose (low glucose). The islets were transferred to
new low glucose Krebs-Ringer buffer and incubated for 60 min. Subse-
quently, the islets were incubated in Krebs-Ringer buffer containing
25 mM glucose (high glucose) for 30 min. The supernatants from the
second low-glucose solution and from the high-glucose solution were
collected for the insulin ELISA assay and stored at−80 °C. Insulin con-
centrations were measured using an Ultra Sensitive Mouse Insulin
ELISA Kit (Morinaga Institute of Biological Science).
2.13. Immunohistochemistry
Rabbits were immunized with peptides corresponding to residues
1140–1153 (C+PASARDREYLESGL) of Trpm5 (Operon Biotechnologies,
Tokyo, Japan). Preincubation of the antibody with peptide antigen
(10 ng/mL) abolished the brush cell staining, conﬁrming the speciﬁcityof the antibody (data not shown). The other primary antibodies used
were as follows: rabbit anti-Skn-1a antibody (#sc-330, Santa Cruz Bio-
technology, Santa Cruz, CA), rabbit anti-Dclk1 antibody (#AP7219b,
Abgent, San Diego, CA), rabbit anti-ChgA antibody (#20085,
ImmunoStar, Hudson, WI), and goat anti-GLP-1 antibody (#sc-7782,
Santa Cruz Biotechnology). Immunohistochemistry was performed as
previously described (Ishimaru et al., 2006). In brief, fresh-frozen sec-
tions (10-μm thick) were ﬁxed in 4% paraformaldehyde (PFA), perme-
abilized with ice-cold methanol, blocked with phosphate-buffered
saline (PBS) containing 5% skim milk, and incubated with rabbit anti-
Skn-1a antibody (1/1000 dilution), rabbit anti-Trpm5 antibody (1/200
dilution), rabbit anti-Dclk1 antibody (1/50 dilution), or rabbit anti-
ChgA antibody (1/200 dilution), followed by incubation with Alexa
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(#A31572, Life Technologies). For GLP-1, fresh-frozen sections (10-μm
thick) were ﬁxed with 4% PFA, blocked with PBS containing 5% normal
donkey serum and 0.2% Triton X-100, and incubated with goat anti-
GLP-1 antibody (1/150 dilution) followed by incubation with Alexa
Fluor 555-conjugated anti-goat IgG (#A21432, Life Technologies).
For double staining, fresh-frozen sections (10-μm thick) were ﬁxed
with 4% PFA and permeabilized with ice-cold methanol followed by an-
tigen retrieval. The sectionswere then blockedwith Tris-buffered saline
with 0.05% Tween 20 (TBST) containing 5% skim milk and incubatedFig. 3.Metabolic phenotypes of Skn-1 KOmice fed a HFD. (a) Changes in body weight under HF
dramatically reduced body weight compared with their WT littermates (n N 54). (b) Skn-1 KO
signiﬁcant differences in muscle mass percentage between the two genotypes (n = 18–26). (c
(d) Skn-1 KO and WT littermates had similar food intake at 8 weeks of age (n = 8–10). (e) Sk
(n = 4). The data are presented as the mean ± SEM; **p b 0.01 and *p b 0.05. See also Fig. S3.with rabbit anti-Trpm5 antibody (1/200 dilution), followed by incuba-
tion with horseradish peroxidase (HRP)-conjugated anti-rabbit IgG
(#31460, Life Technologies) and subsequent reaction with tyramide
signal ampliﬁcation (TSA)-Alexa Fluor 488 (Life Technologies) as a sub-
strate for peroxidase. After antigen retrieval, the sections were
blocked with TBST containing 5% skim milk and incubated with
rabbit anti-Skn-1a antibody (1/300 dilution) or rabbit anti-Dclk1 an-
tibody (1/50 dilution), followed by incubation with Cy3-conjugated
anti-rabbit IgG (#711-165-152, Jackson ImmunoResearch, West
Grove, PA).D conditions. When fed a HFD for 12 weeks after 4 weeks of age, Skn-1 KOmice exhibited
mice had a lower body fat percentage than their WT littermates, whereas there were no
) Skn-1 KOmice had lower tissue weights of epididymal and perirenal WAT (n = 6–12).
n-1 KO mice exhibited increased energy expenditure compared with their WT littermates
Fig. 4. Enhanced catecholamine secretion in Skn-1 KO mice fed a HFD. (a) Serum
triiodothyronine (T3), tetraiodothyronine (T4), and thyroid stimulating hormone (TSH)
were comparable between Skn-1 KO and WT littermates (n = 7–8). (b) Urinary
epinephrine and dopamine were higher in Skn-1 KO mice than their WT littermates
(n = 13–14). The data are presented as the mean ± SEM; *p b 0.05. See also Fig. S4.
66 S. Ushiama et al. / EBioMedicine 8 (2016) 60–712.14. In Situ Hybridization
In situ hybridization was performed as previously described
(Ishimaru et al., 2005). In brief, fresh-frozen sections (10-μm thick) of
the small intestine, including the duodenum, jejunum, and ileum,
were placed on MAS-coated glass slides (Matsunami Glass, Osaka,
Japan) and ﬁxed in 4% PFA in PBS. Prehybridization (at 58 °C for 1 h), hy-
bridization (at 58 °C, 2 O/N), washing (0.2 × SSC at 58 °C), and develop-
ment (NBT-BCIP)were performedusing a digoxigenin-labeled probe for
Trpm5. Stained images were obtained using a ﬂuorescence microscope
(BX51, Olympus, Tokyo, Japan) equippedwith a cooled CCDdigital cam-
era (DP71, Olympus).
2.15. Data Analysis and Statistical Methods
All data are presented as the mean ± SEM. Statistically signiﬁcant
differences were assessed using Student's t-test.
3. Results
3.1. Brush Cells in the GI Tract Are Abolished in Skn-1 KO Mice
We ﬁrst investigated whether Skn-1a plays important roles in the
regulation of cell differentiation in the stomach and small intestine. To
examine the mRNA expression of Skn-1a in the GI tract, we performed
RT-PCR analysis of mRNA from several tissues of WT mice. Skn-1awas
abundantly expressed in the circumvallate papillae, stomach, duode-
num, jejunum, and ileum, but it was absent or only faintly expressed
in all other tissues examined, including the pancreas, islets of
Langerhans, brain, liver, skeletal muscle, white adipose tissue (WAT),
and brown adipose tissue (BAT) (Fig. 1a). RT-PCR of GAPDH as a control
revealed comparable levels in all the tissues other than islets of
Langerhans andWAT, in which slightly less intense bands were detect-
ed (Fig. 1a). To examine the tissue distribution of Skn-1a in the stomach
and intestine at the cellular level, we next performed immunohisto-
chemistry using an anti-Skn-1a antibody. In the stomach, Skn-1a signals
were abundantly detected in the corpus beneath the limiting ridge (Fig.
1b). In the duodenum, jejunum, and ileum, Skn-1a signals were ob-
served in approximately 100 cells per section (Fig. 1b and data not
shown). These results suggest that Skn-1a functions as a transcription
factor that regulates cell differentiation in the stomach and intestine
aswell as in the taste buds, nasal respiratory epithelium, andmain olfac-
tory epithelium (Matsumoto et al., 2011; Ohmoto et al., 2013;
Yamaguchi et al., 2014).
We next examined the expression of Trpm5 in the small intestine. In
situ hybridization analysis using a probe for Trpm5 revealed that Trpm5
signals scattered throughout the small intestine including the duode-
num, jejunum, and ileum, ofWTmice (Fig. 1c and data not shown), con-
sistent with the previous reports (Bezencon et al., 2008). Intriguingly,
no signals of Trpm5were observed in Skn-1 KOmice (Fig. 1c). Immuno-
histochemistry using an anti-Trpm5 antibody conﬁrmed thepresence of
the Trpm5 protein in the duodenum of WT mice but the absence of
Trpm5 protein in Skn-1 KO mice (Fig. S1a).
Doublecortin-like kinase 1 (Dclk1) antibody marks brush cells
(Gerbe et al., 2009, 2011; Saqui-Salces et al., 2011). Chromogranin A
(ChgA) is a marker for enteroendocrine cells (Rindi et al., 2004). GLP-
1 is an incretin, a peptide hormone, secreted from enteroendocrine L
cells (Wu et al., 2015). Signals of Dclk1 were detected in WT mice but
not in Skn-1 KO mice (Fig. 1d). By contrast, signals of ChgA and GLP-1
were observed in WT and Skn-1 KO mice (Fig. S1a). Finally, we per-
formed double staining using antibodies against Trpm5 and Skn-1a or
Dclk1. Nearly all Trpm5-positive cells were also positive for Skn-1a or
Dclk1 (Figs. 1e and S1b). Taken together, these results demonstrate
that brush cells expressing Trpm5 and Dclk1 are abolished in Skn-1 KO
mice and that Skn-1a is a crucial transcription factor for generating
brush cells in the GI tract.3.2. Metabolic Phenotypes of Skn-1 KO Mice Fed a Normal Chow Diet
To examine the effect of eliminating type II taste cells and brush cells
in the GI tract on energy homeostasis, we characterized the metabolic
phenotypes of Skn-1 KO mice. Whereas there was no signiﬁcant differ-
ence in body weight at birth between the Skn-1 KO andWT littermates
(Fig. S2a), Skn-1 KO mice exhibited lower body weight compared to
their WT littermates when weaned at 3 weeks of age (Figs. 2a and
S2a). When fed a normal chow diet, Skn-1 KO mice exhibited signiﬁ-
cantly lower body weight than their WT littermates throughout the
13 weeks after weaning (Fig. 2a). For example, the body weights of
the Skn-1 KO and WT littermates at 16 weeks of age were 27.4 ± 0.5 g
and 29.8 ± 0.4 g, respectively. X-ray computed tomography (CT) anal-
ysis of body composition revealed that Skn-1 KO mice had a lower
body fat percentage than their WT littermates at approximately
20 weeks of age, whereas there was no signiﬁcant difference in muscle
mass percentage between the two genotypes (Fig. 2b). Among blood
chemical parameters, the concentration of serum total ketone bodies
was signiﬁcantly higher in Skn-1 KO mice than in their WT littermates
under ad libitum feeding and 18-h fasting conditions (Fig. 2c and d).
In addition, some parameters related to lipid metabolism, such as cho-
lesterol and non-esteriﬁed fatty acid (NEFA) levels, tended to be higher
in Skn-1 KO mice compared with their WT littermates (Tables S1 and
S2). Collectively, these results demonstrate that lipid metabolism, such
as lipid degradation and β-oxidation of fatty acids, is accelerated in
Skn-1 KO mice.
Despite the lower body weight and body fat percentage of Skn-1 KO
mice, there was no difference in food intake between the Skn-1 KO and
WT littermates at 8 weeks of age (Fig. 2e) and in water intake between
the two genotypes (data not shown). Analysis of the metabolic rates of
the mice revealed that the energy expenditure of Skn-1 KO mice was
higher than that of their WT littermates (Fig. 2f). By contrast, there
were no signiﬁcant differences in the respiratory exchange ratio (RER)
67S. Ushiama et al. / EBioMedicine 8 (2016) 60–71or spontaneous motor activity between the two genotypes (Figs. S2b
and S2c). These results demonstrate that increased energy expenditure
causes reduced bodyweightwith lower body fat percentage in Skn-1KO
mice.
Quantitative real-time PCR (qPCR) analysis revealed that the mito-
chondrial DNA content in the skeletal muscle was signiﬁcantly higher
in Skn-1 KO mice than in their WT littermates (Fig. 2g). Moreover,
DNA microarray analysis revealed enhanced expression of genes in-
volved in mitochondrial function, such as uncoupling proteins 3Fig. 5.Reduced insulin secretion and improved glucose tolerance and insulin resistance in Skn-1
of body weight) when fed a normal chow diet. Blood glucose was comparable between Skn-1
exhibited a smaller increase in plasma insulin for 60 min after administration compared with
after glucose gavage (2.0 mg/g of body weight) of mice fed a HFD. Blood glucose was lower in
(c). Plasma insulin was lower in Skn-1 KO mice than their WT littermates before glucose adm
(n = 25–30) (d). (e) Blood glucose after intraperitoneal administration of insulin (0.75 mU/g
compared with WT littermates (n = 5). The data are presented as the mean ± SEM; **p b 0.0(Ucp3), in Skn-1 KO mice (Table 1). These results suggest that energy
expenditure is increased in the skeletal muscle of Skn-1 KO mice.
3.3. Metabolic Phenotypes of Skn-1 KO Mice Fed a HFD
Wenext examined themetabolic phenotypes of Skn-1 KOmice fed a
HFD. When fed a HFD for N12 weeks after 4 weeks of age, the body
weight of Skn-1 KO mice was dramatically lower than that of their WT
littermates (Fig. 3a). For example, the body weights of Skn-1 KO andKOmice. (a and b) Blood glucose (a) and plasma insulin (b) after glucose gavage (3.0mg/g
KO and WT littermates for 120 min after administration (n = 21–33) (a). Skn-1 KO mice
their WT littermates (n = 20–21) (b). (c and d) Blood glucose (c) and plasma insulin (d)
Skn-1 KO mice than their WT littermates for 120 min after administration (n = 26–30)
inistration (p b 0.05) and tended to be lower at 15 min after administration (p = 0.10)
of body weight) when fed a HFD. Skn-1 KO mice exhibited improved insulin resistance
1 and *p b 0.05. See also Fig. S5.
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respectively. CT analysis of body composition and measurement of tis-
sue mass revealed that Skn-1 KOmice had a lower body fat percentage,
including epididymal andperirenalwhite adipose tissues, than theirWT
littermates at approximately 20 weeks of age, whereas there were no
signiﬁcant differences in theweight ratios of other tissues, such asmus-
cle, between the two genotypes (Fig. 3b and c and Table S3).
Although there was no signiﬁcant difference in food intake between
the Skn-1 KO andWT littermates at 8 weeks of age (Fig. 3d), energy ex-
penditure was higher in Skn-1 KOmice than in theirWT littermates, but
spontaneous motor activity was similar between the two genotypes
(Fig. 3e and data not shown). In addition, we observed no differences
in food intake or fecal triacylglycerol (TG) between the Skn-1 KO and
WT littermates at 15weeks of age (Figs. S3a and S3b). Fecal energy con-
tent was also comparable between the Skn-1 KO and WT littermates
(Fig. S3c). These results suggest that increased energy expenditure is
the primary cause of reduced adiposity in Skn-1 KO mice fed a HFD.
Finally, we measured plasma adiponectin, FGF21, insulin, and leptin
in Skn-1 KO and WT littermates fed a HFD (Table S4). Plasma leptin
tended to be lower in Skn-1 KO mice compared with their WT litter-
mates (p = 0.08).3.4. Catecholamine Secretion is Augmented in Skn-1 KO Mice Fed a HFD
We examinedwhether the levels of thyroid hormones, including tri-
iodothyronine (T3), tetraiodothyronine (T4), and thyroid stimulating
hormone (TSH), and catecholamines, including norepinephrine, epi-
nephrine, and dopamine, were altered in Skn-1 KO mice fed a HFD.
Serum T3, T4, and TSH were comparable between Skn-1 KO andWT lit-
termates (Fig. 4a). We next measured 24-h urinary excretion of cate-
cholamines. Urinary epinephrine and dopamine were signiﬁcantly
higher and norepinephrine tended to be higher (p = 0.06) in Skn-1
KO mice compared to their WT littermates (Fig. 4b). qPCR analysis re-
vealed that the gene expressionof catecholamine biosynthetic enzymes,
including tyrosine hydroxylase (Th), dopa decarboxylase (Ddc), dopa-
mine-β-hydroxylase (Dbh), and phenylethanolamine N-methyltrans-
ferase (Pnmt), in adrenal glands was comparable between Skn-1 KOFig. 6. Schematic representation of the presumed metabolic pathways originating from brush
detected by the tongue and GI tract. In Skn-1 KO mice, the lack of type II taste cells and brush
ketone bodies, and thermogenesis in muscle are increased, whereas insulin secretion from
lower body fat percentage due to higher energy expenditure.and their WT littermates (Fig. S4). These results suggest that catechol-
amines are over-secreted from adrenal glands in Skn-1 KO mice.3.5. Insulin Secretion is Reduced in Skn-1 KO Mice
To examine carbohydrate metabolism in Skn-1 KO mice, we per-
formed an oral glucose tolerance test (OGTT). Blood glucose concentra-
tions in Skn-1KOandWT littermateswere comparable for 120min after
oral glucose administration (Fig. 5a). By contrast, the increase in plasma
insulin 60 min after glucose administration was smaller in Skn-1 KO
mice than in their WT littermates (Fig. 5b). However, plasma GIP and
GLP-1, which potentiate insulin secretion from pancreatic β-cells (Wu
et al., 2015), were comparable between Skn-1 KO and WT littermates
after oral glucose administration (Figs. S5a and S5b).
We next examined the insulin secretion ability of pancreatic β-cells
in Skn-1 KO mice. First, RT-PCR analysis revealed that Skn-1a was not
expressed in the pancreas or islets of Langerhans of WT mice (Fig. 1a).
Second, insulin secretion from isolated islets in response to 25 mM glu-
cose was comparable between Skn-1 KO and WT littermates (Fig. S5c).
Third, in the intraperitoneal glucose tolerance test (IPGTT), blood glu-
cose concentrations were comparable between Skn-1 KO andWT litter-
mates for 120 min after administration (Fig. S5d). Plasma insulin
concentrations were also comparable between Skn-1 KO andWT litter-
mates before and at 15 min after intraperitoneal administration (Fig.
S5e). Collectively, these results demonstrate that insulin secretion
from pancreatic β-cells is normal in Skn-1 KO mice. Finally, the insulin
tolerance test (ITT) revealed that Skn-1KOandWT littermates had com-
parable insulin sensitivity (Fig. S5f).
When fed a HFD, blood glucose was signiﬁcantly lower in Skn-1 KO
mice than their WT littermates for 120 min after oral glucose adminis-
tration (Fig. 5c), demonstrating that impaired glucose tolerance in WT
littermates fed a HFD is improved in Skn-1 KOmice. In addition, plasma
insulin levels were lower in Skn-1 KOmice than in their WT littermates
before glucose administration (p b 0.05) and tended to be lower at
15 min after administration (p = 0.10, Fig. 5d). ITT revealed that the
Skn-1 KO mice had improved insulin resistance compared with their
WT littermates (Fig. 5e). Collectively, these results demonstrate thatcells and type II taste cells in the GI tract. Food components and digested nutrients are
cells results in increased catecholamine secretion. Lipolysis in WAT, serum levels of total
the pancreas is reduced. Consequently, Skn-1 KO mice have reduced body weight with
69S. Ushiama et al. / EBioMedicine 8 (2016) 60–71the insulin resistance and impaired glucose tolerance observed in WT
mice fed a HFD are ameliorated in Skn-1 KO mice.
4. Discussion
In the present study, we demonstrated that brush cells and type II
taste cells in the GI tract (Matsumoto et al., 2011) are unexpectedly
abolished in Skn-1 KO mice. This ﬁnding indicates that Skn-1 is critical
for the development of Trpm5-expressing chemosensory cells in mice.
The Skn-1 KOmice had reduced body weight with a lower body fat per-
centage, primarily due to increased energy expenditure. Furthermore,
catecholamine secretion was increased in Skn-1 KO, accompanied by
decreased insulin secretion. We propose brain-mediated mechanisms
of energy homeostasis originating from brush cells and taste cells in
the GI tract to peripheral tissues including the adrenal glands (Fig. 6).
In detail, taste signals and nutrient stimuli, which are sensed by taste
cells and brush cells in the GI tract are transmitted to the brain via affer-
ent neurons and/or humoral mediators and subsequently conveyed to
adrenal glands that secrete catecholamines via efferent sympathetic
nerves. In Skn-1 KO mice, loss of taste and/or nutrient sensing may in-
tensify the activity of the efferent sympathetic nerves, resulting in exag-
gerated secretion of catecholamines. Based on the network of the gut-
brain axis originating from brush cells and taste cells in the GI tract,
the present study suggests an approach to the treatment of obesity.
Skn-1a is expressed in Trpm5-expressing chemosensory cells. Loss-
of-function of Skn-1a results in the elimination of these cell types
(Matsumoto et al., 2011; Ohmoto et al., 2013; Yamaguchi et al., 2014).
In the present study, we demonstrated that Skn-1a is expressed in
Trpm5-expressing brush cells in the GI tract including stomach and in-
testine. It should be noted that these cells are abolished in the GI tract
of Skn-1 KO mice. Genes encoding sweet taste receptors (T1R2 and
T1R3) and downstream signaling molecules such as gustducin are
expressed in enteroendocrine L cells that secret GLP-1 (Jang et al.,
2007). When glucose was orally administered, the plasma GLP-1 con-
centration was not augmented in gustducin KO mice compared with
WT mice, which resulted in a lack of a rapid increase in plasma insulin
levels and an impaired glucose tolerance (Jang et al., 2007).We showed
that GLP-1 signalswere similar betweenWT and Skn-1KOmice in immu-
nohistochemical analyses, consistent with normal incretin release after
oral glucose administration in Skn-1 KOmice. These results demonstrate
that Skn-1a is also required for the generation of Trpm5-expressing
brush cells, but not for that of enteroendocrine L cells, in the GI tract.
Trpm5 is expressed not only in the chemosensory cells but also in the
mouse pancreatic β-cell line MIN6, pancreatic islets of Langerhans, and
pancreatic β-cells (Colsoul et al., 2010; Nakagawa et al., 2009; Oya et al.,
2011; Prawitt et al., 2003; Yamamoto and Ishimaru, 2013). Trpm5 plays
an important role in the regulation of GSIS from pancreatic β-cells via
two major mechanisms: triggering and amplifying pathways (Brixel et
al., 2010; Colsoul et al., 2010; Liman, 2010). Trpm5 KO mice, like Skn-1
KO mice, gain signiﬁcantly less body weight and fat mass and are
more sensitive to insulin than WT mice when fed either a HFD or a
high-carbohydrate diet (Larsson et al., 2015). T1R3 is the common sub-
unit of sweet (T1R2+T1R3) and umami (T1R1+T1R3) taste receptors
(Yarmolinsky et al., 2009). When fed a HFD, T1R3 KOmice had reduced
fat mass, in spite of unaltered body weight (Simon et al., 2014). T1R3 is
expressed in the gut, pancreas, and adipose tissue as well as in the
tongue (Yamamoto and Ishimaru, 2013). In contrast, Skn-1a was not
expressed in the pancreas, islets of Langerhans, or brain, suggesting
that the tissue distribution of Skn-1a is more restricted than that of
Trpm5 and T1R3. In this context, Skn-1 KO mice are unique models for
investigating unexplored mechanisms underlying the gut-brain axis
and whole-body energy metabolism.
Skn-1 KO mice exhibited lower body weight than their WT litter-
mates after weaning when fed either a normal chow diet or a HFD,
whereas body weight was indistinguishable between Skn-1 KO and
WT littermates at birth. Notably, the Skn-1 KO mice had much lowerbody weight than their WT littermates when fed a HFD; the body
weight gain of Skn-1 KOmice fed a HFD for 12 weeks was nearly equiv-
alent to that ofWTmice fed a chowdiet during the same period, and the
Skn-1 KOmice did not become obese. In Skn-1 KOmice fed a HFD, blood
glucose levels and insulin secretion aswell as insulin tolerancewere im-
proved, and plasma leptin, an indicator of body fat mass, tended to be
lower than in their WT littermates. These results demonstrate that
Skn-1 KO mice are resistant to HFD-induced metabolic dysregulation.
The reduced bodyweight of Skn-1KOmicewas not due to decreased
food intake or nutrient absorption but to increased energy consump-
tion, which resulted in a lower body fat ratio. Skn-1 KO mice exhibited
slightly but signiﬁcantly higher urinary epinephrine and dopamine, im-
plying an increase in the total amounts of these hormones released in
24 h. Because there was no difference in the expression of the biosyn-
thetic enzymes for catecholamine in the adrenal glands, it is unlikely
that this signiﬁcant increase in catecholamine excretion was caused by
catecholamine overproduction. Because peripheral secretion of cate-
cholamine is induced by activation of the sympathetic nervous system
(Watanabe et al., 1988) and Skn-1a is not expressed in the brain, it is
tempting to speculate that the sympathetic nervous system in Skn-1
KO mice is activated by unidentiﬁed signals from the GI tract to the
brain and not alteration of brain function.
In particular, epinephrine and norepinephrine are critical to main-
tain energy production under hypoglycemia and malnutrition through
lipolysis, ketogenesis (Bahnsen et al., 1984; Steiner et al., 1991), and in-
creased mitochondria in skeletal muscle (Miura et al., 2007). In adipo-
cytes, catecholamines induce lipolysis, but insulin inhibits lipolysis
(Nielsen et al., 2014). Consistent with previous reports, the copy number
ofmitochondrial DNA and the concentration of serum total ketone bodies
were increased in Skn-1 KO mice, in accordance with an increase in
energy consumption in this model. These results indicate that the appro-
priate elevation of catecholamine secretion in Skn-1 KOmicemay protect
against obesity and metabolic syndrome. Acute psychosocial stress in-
duces changes in catecholamine sensitivity (Strahler et al., 2015). Pheo-
chromocytoma is a tumor arising from adrenomedullary choromafﬁn
cells that automatically overproduce catecholamines (Lenders et al.,
2014). Patientswith pheochromocytomawith similar levels of circulating
catecholamines exhibit variable phenotypes, possibly due inpart to differ-
ences in hormone sensitivity to the corresponding receptors (Markou et
al., 2015). Catecholamine sensitivity in peripheral tissuesmay be similarly
enhanced by stress signals from the brain in Skn-1 KO mice.
In the OGTT, Skn-1 KO mice exhibited a smaller increase in plasma
insulin compared with their WT littermates, whereas blood glucose
concentrationswere indistinguishable between Skn-1KOandWT litter-
mates. Why did the Skn-1 KO mice exhibit such a reduced increase in
plasma insulin despite similar changes in blood glucose? First, plasma
concentrations of incretins, such as GIP andGLP-1,were comparable be-
tween Skn-1 KO and WT littermates after oral glucose administration,
which is consistent with the immunohistochemical analyses revealing
that GLP-1 signalswere similar betweenWTand Skn-1KOmice. Second,
insulin secretion from pancreatic β-cells was normal in Skn-1 KO mice.
Third, Skn-1 KO and WT littermates showed comparable insulin sensi-
tivity in the ITT. By contrast, urinary epinephrine and dopamine were
signiﬁcantly higher in Skn-1 KO mice than their WT littermates. Cate-
cholamines inhibit insulin secretion from pancreatic β-cells (Barth et
al., 2007). Overexpression of pancreatic alpha2A-adrenergic receptor
in the diabetic Goto-Kakizaki ratmediates adrenergic suppression of in-
sulin secretion (Rosengren et al., 2009). Higher catecholamine secretion
may inhibit insulin secretion in Skn-1 KO mice. Collectively, our results
demonstrate that enhanced catecholamine secretion in Skn-1 KO mice
induces lipolysis in WAT, accelerates β-oxidation of fatty acids in the
liver and skeletal muscle, and, consequently, thermogenesis in skeletal
muscle, and inhibits insulin secretion from the pancreas. A range of di-
verse effects contribute to resistance to HFD-induced obesity and fuel
dyshomeostasis (Fig. 6). Further studies are warranted to elucidate the
molecularmechanisms underlying the regulation of energymetabolism
70 S. Ushiama et al. / EBioMedicine 8 (2016) 60–71originating from brush cells and type II taste cells in the GI tract, e.g.,
identifying which chemosensory receptors are expressed in the brush
cells of the GI tract.
5. Conclusions
In a network of the gut-brain axis, the loss of brush cells and taste
cells in the GI tract alters energy metabolism in Skn-1 KO mice. We
thus propose the concept that taste-receiving cells in the oral cavity
and/or food-borne chemicals-receiving brush cells in the gut are in-
volved in regulation of the body weight and adiposity. The discovery
of food-derived factors that regulate these cells may open new avenues
for the treatment of obesity and diabetes.
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